A Dark Vector Cognition product

Item 6. Selected Financial Data

12K characters. Original on sec.gov · Markdown

Item 6. Selected Financial Data

The following information should be read in conjunction with Globe Life's Consolidated Financial Statements and related notes reported elsewhere in this Form 10-K:

(Dollar amounts in thousands except per share and percentage data)

Year ended December 31,
20202019201820172016
Life$2,672,804$2,517,784$2,406,555$2,306,547$2,189,333
Health1,141,0971,077,3461,015,339976,373947,663
Other44121538
Total premium3,813,9053,595,1343,421,9063,282,9353,137,034
Net investment income927,062910,459882,512847,885806,903
Realized gains (losses)(4,371)20,621(1,804)23,611(10,683)
Total revenue4,737,9214,527,5324,303,7514,155,5733,934,629
Income from continuing operations, net of tax731,773760,882701,5101,458,263539,590
Income from discontinued operations, net of tax—(92)(44)(3,769)10,189
Net income731,773760,790701,4661,454,494549,779
Basic net income (loss) per common share:
Continuing operations6.906.976.2212.534.50
Discontinued operations———(0.03)0.08
Net income6.906.976.2212.504.58
Diluted net income (loss) per common share:
Continuing operations6.826.836.0912.264.41
Discontinued operations———(0.04)0.08
Net income6.826.836.0912.224.49
Cash dividends paid0.740.680.630.590.56
Basic weighted average shares outstanding106,075109,214112,873116,343120,001
Diluted weighted average shares outstanding107,225111,381115,249118,983122,368
As of December 31,
20202019201820172016
Cash and invested assets$22,547,498$19,923,204$17,239,570$17,853,047$15,955,891
Total assets29,046,73125,977,46023,095,72223,474,98521,436,087
Short-term debt254,918298,738307,848328,067264,475
Long-term debt1,667,8861,348,9881,357,1851,132,2011,133,165
Shareholders' equity8,771,0927,294,3075,415,1776,231,4214,566,861
Per diluted common share83.1966.0248.1152.9537.76
Effect of fixed maturity revaluation on diluted equity per common share(1)30.0717.763.7913.185.63
Annualized premium in force:
Life2,739,9492,581,6282,464,7282,373,0992,262,736
Health1,193,3621,139,0381,073,6981,018,020998,634
Total3,933,3113,720,6663,538,4263,391,1193,261,370
Basic shares outstanding103,797107,720110,693114,593118,031
Diluted shares outstanding105,429110,494112,561117,696120,958

(1)See discussion under the caption Capital Resources in Management’s Discussion and Analysis in this report concerning the effect this rule has on Globe Life's equity.

GL 2020 FORM 10-K

CAUTIONARY STATEMENTS

We caution readers regarding certain forward-looking statements contained in the foregoing discussion and elsewhere in this document, and in any other statements made by, or on behalf of Globe Life whether or not in future filings with the Securities and Exchange Commission. Any statement that is not a historical fact, or that might otherwise be considered an opinion or projection concerning the Company or its business, whether express or implied, is meant as and should be considered a forward-looking statement. Such statements represent management's opinions concerning future operations, strategies, financial results or other developments. We specifically disclaim any obligation to update or revise any forward-looking statement because of new information, future developments, or otherwise.

Forward-looking statements are based upon estimates and assumptions that are subject to significant business, economic and competitive uncertainties, many of which are beyond our control, including uncertainties related to the impact of the COVID-19 outbreak on our business operations, financial results and financial condition. If these estimates or assumptions prove to be incorrect, the actual results of Globe Life may differ materially from the forward-looking statements made on the basis of such estimates or assumptions. Whether or not actual results differ materially from forward-looking statements may depend on numerous foreseeable and unforeseeable events or developments, which may be national in scope, related to the insurance industry generally, or applicable to the Company specifically. Such events or developments could include, but are not necessarily limited to:

1.Economic and other conditions, including the COVID-19 pandemic and its impact on the U.S. economy, leading to unexpected changes in lapse rates and/or sales of our policies, as well as levels of mortality, morbidity, and utilization of health care services that differ from Globe Life's assumptions;

2.Regulatory developments, including changes in accounting standards or governmental regulations (particularly those impacting taxes and changes to the Federal Medicare program that would affect Medicare Supplement);

3.Market trends in the senior-aged health care industry that provide alternatives to traditional Medicare (such as Health Maintenance Organizations and other managed care or private plans) and that could affect the sales of traditional Medicare Supplement insurance;

4.Interest rate changes that affect product sales and/or investment portfolio yield;

5.General economic, industry sector or individual debt issuers’ financial conditions (including developments and volatility arising from the COVID-19 pandemic, particularly in certain industries that may comprise part of our investment portfolio) that may affect the current market value of securities we own, or that may impair an issuer’s ability to make principal and/or interest payments due on those securities;

6.Changes in the competitiveness of the Company's products and pricing;

7.Litigation results;

8.Levels of administrative and operational efficiencies that differ from our assumptions (including any reduction in efficiencies resulting from increased costs arising from operating during the COVID-19 pandemic);

9.The ability to obtain timely and appropriate premium rate increases for health insurance policies from our regulators;

10.The customer response to new products and marketing initiatives;

11.Reported amounts in the consolidated financial statements which are based on management estimates and judgments which may differ from the actual amounts ultimately realized;

12.Compromise by a malicious actor or other event that causes a loss of secure data from, or inaccessibility to, our computer and other information technology systems;

13.The severity, magnitude and impact of the COVID-19 pandemic, including effects of the pandemic and the effects of the U.S. and state governments' and other businesses’ response to the pandemic, on our operations and personnel, and on commercial activity and demand for our products; and

14.Our ability to access the commercial paper and debt markets, particularly if such markets become unpredictable or unstable for a certain period as a result of the COVID-19 pandemic.

Readers are also directed to consider other risks and uncertainties described in other documents on file with the Securities and Exchange Commission.

GL 2020 FORM 10-K

GLOBE LIFE INC.

Management's Discussion & Analysis

Previous: Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities · Next: Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations